Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
endothelin-3
- Development stage
- Unknown
- Lead developer
- University of Edinburgh
- Modality
- Peptides
- Administration
- Intra-arterial
01
Overview
Endothelin-3 (ET-3) is an endogenous 21-amino acid peptide and a member of the endothelin family. In clinical research conducted by the University of Edinburgh, it is utilized as a selective endothelin B (ETB) receptor agonist to investigate the vascular effects of endothelin receptor antagonists like bosentan and sitaxsentan. ET-3 primarily induces vasodilation through the activation of endothelial ETB receptors, which triggers the release of nitric oxide and prostacyclin. This specific study aims to characterize the role of ETA and ETB receptors in regulating plasma endothelin-1 (ET-1) levels and the vasodilator response in humans, particularly in the context of conditions like pulmonary arterial hypertension (PAH).
- Other names
- Endothelin 3Endothelin3Endothelin-3ET3ET-3ET 3
02
Targets
EDNRA (Endothelin receptor type A)EDNRB (Endothelin receptor type B)
Beyond the preview
Go deeper on endothelin-3.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on endothelin-3.